3 results were returned
European Medicines Agency (EMA) had communicated to third parties (with some omissions), information contained in toxicological test reports and clinical trial reports obtained in a MA application file on the grounds ...
A brief overview of the challenges created by the COVID-19 crisis, the coping strategies of competition authorities, and suggestions on what can be done if you are working on a project requiring merger control approval.
In the fall of next year, the long anticipated EU Foreign Direct Investment Screening Regulation will apply. The regulation is likely to have a significant impact on FDI within the EU – both within Member States that ...